• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    GCC Neurology Devices Market

    ID: MRFR/HC/50065-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    GCC Neurology Devices Market Research Report By Product Type (neurostimulation, interventional neurology, CSF management, neurosurgery devices) and By End-user (hospitals & clinics, specialty center)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    GCC Neurology Devices Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    GCC Neurology Devices Market Summary

    The GCC Neurology Devices market is projected to grow significantly from 392.2 USD Million in 2024 to 1134.6 USD Million by 2035.

    Key Market Trends & Highlights

    GCC Neurology Devices Key Trends and Highlights

    • The GCC Neurology Devices market is valued at 392.2 USD Million in 2024.
    • By 2035, the market is expected to reach 1134.6 USD Million, indicating robust growth.
    • The market is anticipated to grow at a CAGR of 10.14% from 2025 to 2035.
    • Growing adoption of advanced neurology devices due to increasing prevalence of neurological disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 392.2 (USD Million)
    2035 Market Size 1134.6 (USD Million)
    CAGR (2025-2035) 10.14%

    Major Players

    Philips Healthcare, Siemens Healthineers, Neurocrine Biosciences, Boston Scientific, Abbott Laboratories, Medtronic, Terumo Corporation, Stryker, Natus Medical, IntraTherapeutics, Cochlear Limited, NeuroPace, Elekta, GE Healthcare, Zoll Medical Corporation

    GCC Neurology Devices Market Trends

    A number of reasons are contributing to the notable growth of the GCC Neurology Devices Market. Advanced neurology equipment are in high demand due to the region's rising prevalence of neurological illnesses, which is partially caused by ageing populations and changing lifestyles.

    The nations of the Gulf Cooperation Council are also making significant investments in healthcare infrastructure, including cutting-edge facilities for neurological care. In addition to enhancing patient outcomes, this investment is promoting innovation in the field of neurology devices. This market has a lot of untapped potential, especially in the areas of telemedicine and minimally invasive equipment.

    Devices that allow patients to communicate with medical professionals remotely are becoming more and more popular as GCC healthcare providers embrace digital health technologies. This change emphasises the need for effective neurology equipment made for home use or outpatient settings, in addition to improving patient access to care.

    Additionally, local medical device manufacture is being encouraged by regional governments, creating opportunities for alliances and cooperation with foreign companies. Recent patterns show that neurology is moving towards personalised medicine, with a focus on gadgets that meet the needs of specific patients.

    Innovations like neurostimulation devices and AI-powered diagnostic tools are being introduced in the GCC region to increase the effectiveness of treatment.

    Additionally, neurological gadgets that treat mental health diseases are becoming more popular in the market as awareness of mental health issues rises. All of these changes are influencing the GCC's neurology devices market going forward, opening the door to better patient care and more treatment alternatives.

    Market Segment Insights

    GCC Neurology Devices Market Segment Insights

    GCC Neurology Devices Market Segment Insights

    Neurology Devices Market Product Type Insights

    Neurology Devices Market Product Type Insights

    The GCC Neurology Devices Market is increasingly diversified, reflecting the distinct needs and preferences in the region's healthcare landscape. Among the various product types, neurostimulation devices have gained considerable interest due to their effectiveness in treating chronic pain and neurological disorders.

    This segment has witnessed a surge in demand as health systems in the Gulf Cooperation Council (GCC) area actively invest in advanced technologies to provide innovative therapies for conditions such as epilepsy and Parkinson's disease.

    The interventional neurology category is also significant, primarily due to its focus on minimally invasive procedures for treating brain conditions, which are becoming popular in hospitals across GCC member states. This partially stems from the growing incidence of cerebrovascular diseases, prompting healthcare providers to seek efficient and effective treatment options.

    Furthermore, cerebrospinal fluid (CSF) management devices play a critical role in the region's healthcare offerings, addressing the needs arising from conditions resulting in abnormal CSF dynamics. This segment gains traction especially in hospitals focusing on treating patients with serious neurological disorders that necessitate careful monitoring and management.

    Neurology Devices Market

    Neurology Devices Market End-user Insights

    The End-user segment of the GCC Neurology Devices Market encompasses vital sectors such as hospitals and clinics, as well as specialty centers, playing a crucial role in enhancing patient care in neurological disorders. Hospitals and clinics are typically the primary providers of neurology devices, catering to a broad patient demographic and ensuring widespread access to necessary treatments.

    The rising prevalence of neurological conditions in the GCC region has spurred investment in advanced diagnostic and therapeutic devices within these facilities.

    Specialty centers, focusing specifically on neurological care, are significant as they provide tailored services and innovative treatments, often integrating state-of-the-art technology and specialized personnel to enhance treatment outcomes.

    Get more detailed insights about GCC Neurology Devices Market Research Report- Forecast to 2035

    Key Players and Competitive Insights

    The competitive insights of the GCC Neurology Devices Market reveal a landscape characterized by rapid advancement and increasing adoption of innovative technologies aimed at improving diagnosis and treatment for neurological disorders.

    The market is influenced by several factors including rising incidences of neurological diseases, growing awareness of brain-related health issues, and the increasing integration of advanced technology within the healthcare infrastructure.

    As a result, the competitiveness within this sector is shaped by a combination of established players, emerging companies, and collaborations focused on enhancing patient outcomes through cutting-edge medical devices and therapies.

    Philips Healthcare stands out in the GCC Neurology Devices Market due to its robust portfolio of advanced imaging solutions and neuro diagnostics. The company excels with its commitment to innovation and the integration of digital technologies in healthcare, which significantly enhances diagnostic accuracy and treatment outcomes.

    Philips Healthcare also enjoys strong relationships with healthcare providers across the GCC, enabling them to deliver tailored solutions to meet specific patient and institutional needs. Their advanced EEG and MRI devices are particularly notable and well-regarded within the region, thereby strengthening their market presence.

    Furthermore, Philips Healthcare tends to leverage strategic partnerships and collaborations with local health authorities and organizations to continually refine its product offerings, positioning itself as a leader in advancing neurological care.

    In the context of the GCC Neurology Devices Market, Siemens Healthineers has established a formidable presence with its extensive array of medical technologies, including advanced imaging systems and diagnostic tools that are essential in treating neurological conditions.

    The company is known for its innovative offerings such as MRI, CT, and other advanced modalities designed for neurological applications. Siemens Healthineers places a strong emphasis on research and development, consistently striving to enhance its product portfolio in line with the latest technological advancements.

    The company's ability to maintain strategic mergers and acquisitions has also played a strategic role in strengthening its market dominance.

    Through these initiatives, Siemens Healthineers has positioned itself to effectively address the unique healthcare challenges of the region, thus enhancing its value proposition in the GCC Neurology Devices Market and contributing positively to patient care and clinical outcomes.

    Key Companies in the GCC Neurology Devices Market market include

    Industry Developments

    The GCC Neurology Devices Market has seen significant developments recently, particularly with advancements in medical technologies and therapeutic solutions. Companies like Philips Healthcare and Siemens Healthineers are continuously innovating, offering state-of-the-art devices for neurological assessment and treatment.

    In September 2023, Medtronic announced a major growth initiative focused on expanding its portfolio in the GCC to address the rising prevalence of neurological disorders in the region. Several companies have benefitted from mergers, such as Abbott Laboratories acquiring a smaller firm specializing in neurostimulation technologies in August 2023, enhancing their product offerings.

    Similarly, Boston Scientific has been strategically investing in Research and Development to launch new devices tailored to GCC healthcare needs. The market has also experienced a shift in consumer preferences towards minimally invasive treatments, prompting companies like Stryker and Terumo Corporation to adapt their strategies accordingly.

    Current estimates from local health authorities highlight an increased market valuation for neurology devices, driven by heightened awareness and demand for advanced neurological care solutions. Over the last few years, initiatives by the GCC governments to improve healthcare infrastructure have positively influenced investment in neurotechnology, fostering innovation and growth within this sector.

    Market Segmentation

    Neurology Devices Market End-user Outlook

    • hospitals & clinics
    • specialty center

    Neurology Devices Market Product Type Outlook

    • neurostimulation
    • interventional neurology
    • CSF management
    • neurosurgery devices

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 363.8(USD Million)
    MARKET SIZE 2024 392.25(USD Million)
    MARKET SIZE 2035 1134.58(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 10.137% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Philips Healthcare, Siemens Healthineers, Neurocrine Biosciences, Boston Scientific, Abbott Laboratories, Medtronic, Terumo Corporation, Stryker, Natus Medical, IntraTherapeutics, Cochlear Limited, NeuroPace, Elekta, GE Healthcare, Zoll Medical Corporation
    SEGMENTS COVERED Product Type, End User
    KEY MARKET OPPORTUNITIES Telemedicine integration, Growing aging population, Increasing neurological disorders, Advanced imaging technologies, Government healthcare investments
    KEY MARKET DYNAMICS Technological advancements, Increasing prevalence of neurological disorders, Growing aging population, Rising healthcare expenditure, Enhancements in surgical techniques
    COUNTRIES COVERED GCC

    FAQs

    What is the expected market size of the GCC Neurology Devices Market in 2024?

    The GCC Neurology Devices Market is expected to be valued at 392.25 million USD in 2024.

    What will be the projected market size of the GCC Neurology Devices Market by 2035?

    By 2035, the GCC Neurology Devices Market is anticipated to reach a valuation of 1134.58 million USD.

    What is the expected CAGR for the GCC Neurology Devices Market from 2025 to 2035?

    The expected compound annual growth rate for the GCC Neurology Devices Market is 10.137% from 2025 to 2035.

    Which product type will dominate the GCC Neurology Devices Market in 2024?

    In 2024, neurostimulation is anticipated to dominate the market with a valuation of 120 million USD.

    What is the projected value of interventional neurology in the GCC Neurology Devices Market by 2035?

    Interventional neurology is projected to reach a market value of 285 million USD by 2035.

    Who are the key players in the GCC Neurology Devices Market?

    Major players in the GCC Neurology Devices Market include Philips Healthcare, Siemens Healthineers, Medtronic, and Boston Scientific.

    What is the expected market size for csf management devices in 2024?

    The market size for csf management devices is expected to be 70 million USD in 2024.

    What are the anticipated growth opportunities in the GCC Neurology Devices Market?

    The market is expected to experience growth opportunities driven by increasing neurological disorders and advancements in technology.

    What will be the projected market size for neurosurgery devices in 2035?

    Neurosurgery devices are projected to reach a market size of 306.58 million USD by 2035.

    How do current global scenarios impact the GCC Neurology Devices Market?

    Current global scenarios are likely to influence the market dynamics and growth trajectory of the GCC Neurology Devices Market.

    GCC Neurology Devices Market Research Report- Forecast to 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials